M
VERV

MOTCO’s Verve Therapeutics VERV Stock Holding History

MOTCO’s Portfolio VERV Stock Details VERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1
Closed -$19 – 956
2023
Q2 		$19 Buy
+1
New +$17 ﹤0.01% 1031

Other funds holding VERV

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

MOTCO's VERV Position: Q3 2023 in Review

MOTCO sold out of Verve Therapeutics (VERV) in Q3 2023, closing a stake of 1 share — an estimated $19 sold.

MOTCO first reported a position in VERV in Q2 2023 and held it in 1 quarter. The position peaked at $19 in Q2 2023. 134 funds tracked by Wall St. Rank hold VERV as of Q3 2023.

  • MOTCO reported no remaining Verve Therapeutics position as of Q3 2023 after selling out during the quarter.
  • MOTCO sold 1 Verve Therapeutics share in Q3 2023, an estimated $19.
  • MOTCO first reported a position in Verve Therapeutics in Q2 2023 and held it in 1 quarter.
  • MOTCO's Verve Therapeutics position peaked at $19 in Q2 2023.
  • 134 funds tracked by Wall St. Rank held Verve Therapeutics as of Q3 2023.

Based on MOTCO's 13F filing for Q3 2023, filed 7 Nov 2023.